Sarepta Therapeutics Inc. (SRPT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sarepta Therapeutics Inc.

    NASDAQ: SRPT · Real-Time Price · USD
    18.46
    -0.49 (-2.59%)
    At close: Sep 04, 2025, 3:59 PM
    18.48
    0.11%
    After-hours: Sep 04, 2025, 07:42 PM EDT

    Sarepta Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.9B 1.24B 933.01M 701.89M
    Cost of Revenue
    		 319.1M 150.34M 139.99M 97.05M
    Gross Profit
    		 1.58B 1.09B 793.02M 604.84M
    Operating Income
    		 218.08M -267.82M -536.2M -449.71M
    Interest Income
    		 71.77M 85.97M 27.72M 354K
    Pretax Income
    		 260.77M -520.1M -689.96M -418.95M
    Net Income
    		 235.24M -535.98M -703.49M -418.78M
    Selling & General & Admin
    		 557.87M 481.87M 451.42M 282.66M
    Research & Development
    		 804.52M 877.39M 877.09M 771.18M
    Other Expenses
    		 2.4M 1.56M 714K 706K
    Operating Expenses
    		 1.36B 1.36B 1.33B 1.05B
    Interest Expense
    		 18.39M 22.01M 53.25M 63.52M
    Selling & Marketing Expenses
    		 n/a 28.6M 14.6M 7.7M
    Cost & Expenses
    		 1.68B 1.51B 1.47B 1.15B
    Income Tax Expense
    		 25.54M 15.88M 13.53M -168K
    Shares Outstanding (Basic)
    		 95.08M 92.4M 87.56M 81.26M
    Shares Outstanding (Diluted)
    		 107.88M 92.4M 87.56M 81.26M
    EPS (Basic)
    		 2.34 -5.8 -8.03 -5.15
    EPS (Diluted)
    		 2.34 -5.8 -8.03 -5.15
    EBITDA
    		 333.06M -439.2M -582.12M -306.08M
    EBIT
    		 279.17M -498.09M -636.72M -355.42M
    Depreciation & Amortization
    		 53.89M 58.89M 54.6M 49.34M

    Add to Watchlist